Chris Astle has been CFO at Allergan for five months, having previously been the Senior Finance Director at the multinational pharmaceutical giant. Chris has spent several years managing FP&A during times of high growth and change, both from the ground up and refining an established model, along with leading integration and restructuring initiatives and in delivering M&A/contract modelling.
5101
1